White Papers

Oct 01, 2017
Sponsored Content
First-In-Human clinical trials are part of the exploratory early phase of drug development and represent a significant milestone in the clinical development of new medicines. Since only preclinical data are available to guide study design, including dose-selection, population, safety monitoring, appropriate expertise is critical to guarantee the safety of study participants as well as the quality of the data. The purpose of this article is to discuss some practical considerations for the design of FIH clinical trials, considering the current pharmaceutical and biotech drug discovery approach.
Oct 01, 2017
Sponsored Content
Backed by extensive usability research and, most importantly, the patient's voice, this new body map creates the ultimate user experience and delivers a more complete picture of symptom locations. Watch this on-demand webinar to learn key research findings and see our new body map revealed.
Oct 01, 2017
Sponsored Content
One of the most common concerns we hear is regarding the migration of existing paper instruments to an electronic platform. Where do we start? How do we ensure a smooth migration? What can we do to ensure regulatory requirements are satisfied? In this eBook, learn the necessary steps and key considerations for a successful migration.
Oct 01, 2017
Sponsored Content
Chesapeake IRB and CRF Health team up for a collaborative webinar to discuss informed consent oversight and visibility and why Top Pharma is turning to Electronic Informed Consent (eConsent) to exceed in these areas.
Oct 01, 2017
Sponsored Content
Which parts of the protocol should you pay particular attention to when designing an eCOA solution? Industry expert, Dr. Jill Platko, reveals 3 that play a key role in every eCOA design.
Oct 01, 2017
Sponsored Content
Frontage possesses wide experience in running complex studies with controlled substances. This case study features a clinical study of abuse-deterrent formulation involving Gastric PH Monitoring.
native1_300x100
lorem ipsum